Introduction
Atherosclerosis is a chronic inflammatory disease of the artery wall wherein macrophages play a major role. An impaired response to endothelial damage, involving subendothelial accumulation of lipid-loaded macrophages, drives the way to development of atherosclerotic plaques, through multiple inflammatory pathways. 1 Infiltrating macrophages uptake low-density lipoprotein (LDL), especially if they are oxidized (oxLDL), triggering intracellular events that culminate in the release of pro-inflammatory cytokines 2 and eventual macrophage apoptosis. 3 Persistent macrophage apoptosis and impaired clearance of apoptotic bodies contribute to propagate inflammation in atherosclerosis, 4 although the net effect of macrophage apoptosis on lesion progression depends on disease stage. 5 The exact molecular pathways elicited in macrophages exposed to oxLDL are partly unknown. Several cellular functions are epigenetically regulated by microRNAs (miRNAs), endogenous, small non-coding RNAs that play crucial roles in modulating gene expression at post-transcription processing steps, thus impacting on a variety of physiological and pathological processes. 6, 7 miRNAs are key regulators of lipid metabolism and several signalling pathways involved in atherosclerosis and cardiovascular diseases. [8] [9] [10] [11] In addition to modulating gene expression at a cell-autonomous level, miRNAs are released within microparticles 12 and participate in inter-cellular communication. 13 Several circulating miRNAs have been identified as biomarkers for cardiovascular disease using clinical and translational approaches, 14 some of which can be considered suitable targets of therapy.
We herein employed a rigorous strategy for discovery and validation of circulating miRNAs associated with prevalence and incidence of atherosclerosis in a cohort from the general population. We identified miR30c-5p as being negatively associated with cholesterol levels, carotid intima-media thickness and early plaque development. In vitro, we report that downregulation of miR-30c-5p in macrophage-derived microparticles is responsible for the effects of oxLDL on IL-1b release and macrophage apoptosis. In mice, miR-30c-5p knockdown impaired endothelial recovery after injury. We conclude that the observed reduction of circulating miR-30c-5p seen in humans who develop early atherosclerosis is responsible for the pro-inflammatory events in the artery wall, thereby identifying miR-30c-5p as a potential target of therapy.
Methods
For details, see Supplementary material online.
Human study design
The study included 99 subjects randomly selected from the PLIC (Progression of Lesions in the Intima of the Carotid) study, a prospective trial designed to investigate the presence and progression of atherosclerotic lesions in the carotid artery, along with cardiovascular risk factor determination. 15 The study was approved by the Ethics Committee of the University of Study of Milan (approved on 06-02-2001 SEFAP protocollo no. 0003/2001), and conducted in accordance with the principles of the Declaration of Helsinki. All participants signed a written informed consent.
microRNA quantification
MicroRNA from plasma samples was extracted using the miRCURY TM RNA isolation kit-Biofluids (Exiqon, Vedbaek, Denmark). MicroRNA expression profiling was performed using reagents from Exiqon. Individual miRNAs were detected by qPCR for validation.
Cell culture
The THP-1 cell line was obtained from American Type Culture Collection (Manassas, VA, USA). Cells were cultured in supplemented RPMI 1640 medium (Sigma, St. Louis, MO, USA). For the induction of macrophage differentiation, cells (1-2Â10 6 per ml) were seeded with 100 nM PMA (Sigma Aldrich, St. Louis, MO, USA) for 72 h.
Gene expression
miRNA and total RNA were isolated from THP-1 transformed macrophages and from microparticles by miRNeasy Mini kit and by RNeasy MinElute Cleanup Kit (Qiagen, Hilden, Germany). cDNA was synthesized with 500 ng of RNA extracted using iScript cDNA synthesis kit (Bio-Rad, Hercules, CA, USA). Quantitative real-time polymerase chain reaction assay was performed in a Bio-Rad CFX96 Real-Time PCR detection system. The comparative cycle threshold method (DDCq) was used to obtain the relative fold change of gene expression.
Western blot
THP-1 transformed macrophages were lysed in RIPA buffer including protease inhibitors and cell lysates were separated by SDS-PAGE electrophoresis using a 10% polyacrylamide gel. Then proteins were electroblotted onto nitrocellulose membranes and exposed to the relevant antibodies. Protein bands were visualized using an enhanced chemiluminescence detection system (Pierce Biotechnology, Rockford, IL, USA). The blots were scanned and quantified using a chemiluminescence molecular imaging system (Versa Doc 3000, Bio-Rad, Hercules, CA, USA). The results were expressed as densitometric evaluations normalized to tubulin, used as internal control.
Detection of apoptosis
The Annexin V-FITC apoptosis detection kit (eBioscience, San Diego, CA, USA) was used according to manufacturer's instructions.
Microparticle analysis
The supernatants from cell culture were first centrifuged at 3000 g for 10 min and then at 18 000 g for 40 min to obtain microparticles (MPs).
MPs were identified by size and Annexin V-FITC labelling (eBioscience, San Diego, CA, USA). MP staining and incorporation into macrophages was performed as follows: 1000 MPs/lL were stained with 1 lM calcein-AM (Sigma-Aldrich, St. Louis, MO, USA), washed and resuspended in PBS for the incorporation into macrophages (0.5 Â 10 6 cells). Images were captured using a Zeiss microscope equipped with Apotome upgrade for confocal imaging (Carl Zeiss, Dublin, CA, USA).
CD36 silencing
THP-1 transformed macrophages were cultured with 100 nM of siRNA against CD36 or scrambled siRNA for 24-48 h. Efficiency of siRNA knock-down was determined by qPCR. Validated Silencer Select siRNA pre-designed sequences were purchased from Ambion/Applied Biosystems, Foster City, CA, USA.
3 0 UTR luciferase reporter assay
For the validation of Caspase-3 (CASP3) as a target of miR-30c-5p, 3 0 UTR of human CASP3 and a 3'UTR mutant were cloned into a mammalian expression vector and with dual luciferase reporter system (GeneCopoeia, Rockville, MD, USA). THP-1 transformed macrophages were transfected with miR-30c-5p mimic (100 nM), with miR-30c-5p inhibitor (100 nM), or negative controls (Exiqon, Vedbaek, Denmark) using Lipofectamine 2000 following manufacturer's instructions (Invitrogen, Waltham, MA, USA). Twenty-four hours after transfection, dual luciferase assays were performed using the Dual-Glo Luciferase Assay System (Promega, Madison, WI, USA). Firefly luciferase activity was normalized to the corresponding Renilla luciferase activity.
Dicer overexpression
For electroporation, THP-1 transformed macrophages were diluted in transfection buffer "Nucleofector Solution V" (Lonza, Cologne, Germany), and then transfected with a Dicer full-length cDNA encoding plasmid, pDEST-mycDicer (Addgene plasmid 19873). The transfection of plasmid was carried out by electroporation using a control vector. guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes. During anesthesia with inhaled isoflurane, the left carotid artery was exposed and injured by electricity with a bipolar tweezer. Three days later, the extent of residual endothelial damage was evaluated by tail vein injection of 500 mL of 1% Evans blue. Mice were then sacrificed by overdose of inhaled carbon dioxide and blood, liver, as well as the left damaged and right uninjured carotid arteries were collected. For the antagomir experiment described in the method section, n = 6 mice per group were used. In separate experiments, infiltration of inflammatory cells in the injured and uninjured carotid arteries was compared by flow cytometry after staining with CD115, Gr-1, and F4/80 according to a previously described gating protocol. 16 
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Statistical analysis
Where not specified, experiments were performed with n > 5 different replicates. Triplicate technical replicate was normally done. Normal distribution of variables was checked with the Shapiro-Wilk test and nonnormal data were log transformed before analysis. Comparisons between two or more groups were performed using two-tail Student's t test or ANOVA (with Bonferroni correction), respectively. ROC curve analyses were performed with the MedCalc TM software (vers. 15.6 MedCalc Software, Mariakerke, Belgium). Statistical significance was accepted at P < 0.05, but higher statistical significance was sought for most experiments, with a pre-specified threshold of P < 0.01. SPSS ver 23 (SPSS Inc., Chicago, IL, USA) was used.
Results
Strategy for discovery and validation of miRNAs associated with prevalent and incident atherosclerosis
We analysed plasma miRNAs in a randomly selected subgroup of n = 99 participants from the PLIC study, a longitudinal evaluation of carotid plaque development in individuals who were free from atherosclerosis at baseline (T0). 15 At the first follow-up after an average of 5.1 ± 0.2 years (T1), 46 participants had developed a plaque; after the second follow-up after further 6.5 ± 0.3 years (T2) 22 more participants had carotid plaques. We first performed a cross-sectional screening of plasma miRNAs associated with carotid atherosclerosis in samples collected at T1. Individuals with carotid plaques had a higher carotid intima media thickness (CIMT) and an abnormal lipid profile in comparison with individuals without carotid plaques (see Supplementary material online, Table S1 ).
After qPCR validation, selected miRNAs were measured in samples collected at T0 to verify if they predicted carotid plaque development at T1 and T2. Supplementary material online, Figure S1 shows the flowchart of the PLIC study visits, as well as the discovery and validation strategies for circulating miRNAs associated with atherosclerosis.
Profiling of plasma miRNAs
An analysis of 179 miRNAs was performed on a sample of test subjects to identify candidate miRNAs exhibiting altered expression in plasma from individuals with carotid plaques (n = 8), as compared with those without (n = 8) at T1. After excluding three low-abundant miRNAs (Ct value > 35), a set of 176 miRNAs remained for further analysis. To identify miRNAs that were differentially expressed in a statistically significant manner, we performed Volcano plot filtering between the two groups, using the following criteria for up-or down-regulated miRNAs: absolute fold change > _2 and P value < _0.05 ( Figure 1A) . By using the significance analysis of microarrays (GeneEX, Exiqon, Vedbaek, Denmark) algorithm, we identified seven miRNAs, which were differentially expressed in plasma samples from the two groups of patients: five miRNAs were upregulated (miR-142-3p, miR-22-3p, miR-222-3p, miR-144-3p, and miR-15 b-5p), while two were downregulated (miR-199a-3p and miR30c-5p) (see Supplementary material online, Table S2 ).
miRNAs validation with qRT-PCR
Candidate miRNAs selected by the aforementioned unbiased analysis were validated in n = 99 participants of the PLIC study using qRT-PCR on samples collected at T1. For reference gene selection, we performed analysis using two different algorithms (NormFinder and geNorm). miR103a-3p showed a high stability across all samples and this microRNA was used for gene expression normalization (see Supplementary material online, Figure S2 ), as done previously by others. 17, 18 The expression levels of miR-222-3p, miR-199a-3p, miR-15b-5p, miR-144-3p, and miR30c-5p showed significant differential expression in the same direction as in the discovery set, while no significant differences were detected in the expression levels of miR-142-3p and miR-22-3p ( Figure 1B) . ROC curve analyses were performed to determine the discrimination capacity of the four miRNAs with significant odd ratios against carotid plaque prevalence (miR-30-5p, miR-222-3p, miR-144-3p, and miR-199a-3p). miR-30c-5p displayed the best discriminatory capacity of patients with carotid plaques, with an AUC of 0.90 ( Figure 1C ).
Clinical correlations of candidate circulating microRNA levels
We then explored correlations between the levels of the candidate miRNAs (miR-222-3p, miR-199a-3p, miR-15-5b, miR-144-3p, and miR30c-5p) and clinical variables. Inverse correlations were observed between miR-30c-5p total and LDL cholesterol concentrations, and systolic blood pressure. A direct correlation was found between miR-144-3p and age. No significant correlation was found for the other candidate microRNAs (see Supplementary material online, Table S3 ). A negative correlation was detected between circulating miR-30c-5p levels and the CIMT values (r = -0.25; P = 0.013; Figure 1D ). We also conducted logistic regression analyses using five miRNAs differentially expressed between groups (miR-222-3p, miR-199a-3p, miR-15b-5p, miR-144-3p, and miR-30c-5p) to determine the relative risk ratio for the prevalence of carotid plaques. Supplementary material online, Table S4 shows that four miRNAs resulted with a significant odds ratio: miR-30c-5p, miR-222-3p, miR-199a-3p, and miR-144-3p, with the strongest independent effect for miR-30c-5p. 3 .5 Low plasma miR-30c-5p levels predict the development of carotid plaques miR-30c-5p was the miRNA most strongly associated with the presence of carotid plaques at T1. We, therefore, quantified levels of miR-30c-5p in plasma samples collected at T0 to evaluate whether they predict future development of atherosclerosis at T1 and T2. Baseline plasma levels of miR-30c-5p were significantly lower in participants who developed carotid plaques at T1 (P = 0.013) and at T2 (P = 0.006). Therefore, reduction of plasma miR-30c-5p is associated with prevalent atherosclerosis and precedes plaque development by up to 11 years ( Figure 1E) . (E) Association between baseline (T0) plasma levels of miR-30c-5p (normalized to miR-103a-3p) future development of carotid plaques at the first (T1) and the second (T2) follow-up; P values are shown for t-test after log-transformation. (F) miR-30c-5p expression normalized to miR-103a-3p in total plasma, MP-depleted plasma and isolated MPs in a subsample of 11 patients (*P < 0.01 for paired t-test in the indicated comparisons; n.s., not significant). In all panels, scatter plots are shown along with median and interquartile range. 
miR-30c-5p in macrophage-derived microparticles and inflammation
As plasma levels of miR-30c-5p were reduced in patients with an abnormal lipid profile who developed carotid plaques, we hypothesized that miR-30c-5p might be affected by a lipid-responsive pathway involved in the development of atherosclerosis. Monocyte-derived macrophages play a key role in the atherosclerotic process and in perpetuating inflammation within the lesions 1 and the monocytic leukemic cell line THP-1 models macrophage function in atherosclerosis. 19 Therefore, we used macrophages derived from THP-1 cells to study the mechanisms whereby circulating miR-30c-5p may be affected by lipotoxicity and involved in vascular disease. Microparticles (MPs) derived from different cell types are actively involved in promoting or preventing atherosclerosis, they convey nucleic acids signals to target cells, and are a major source of circulating miRNAs. 12 We first verified whether MPs may represent the major source of miR-30c-5p in the plasma. We found that miR-30c-5p levels were on average 45.5 ± 9.4% lower in MP-depleted plasma, but not in isolated MPs compared with total plasma ( Figure 1F) . Therefore, we focused on miRNAs contained in macrophage-derived microparticles, enriching for particles 100-1000 nm in diameter. We first checked whether miR-30c-5p release by macrophages is modulated by proatherogenic factors. Macrophages were treated with palmitic acid, oxLDL, high level of glucose, or TNF-a to mimic dyslipidemic, dysmetabolic, and inflammatory conditions. As a positive control, macrophages were serum-starved for 24 h, because starvation induces the release of apoptotic microparticles. 20 Flow cytometry analysis showed that the release of apoptotic microparticles was higher when macrophages were serum-starved or treated with oxLDL, palmitic acid, and TNF-a, but not with high glucose (Figure 2A and B) . Then, we measured miR-30c-5p content in microparticles released by macrophages. The expression of miR30c-5p was lower in microparticles from macrophages treated with oxLDL or palmitic acid ( Figure 2C ). To check whether microparticles are a major source of miR-30c-5p, we determined the miR-30c-5p expression in the presence or in the absence of microparticles in the medium: data show that the microparticles provide a major contribution to extracelullar miR-30c-5p expression (see Supplementary material online, Figure S3A ). To assess specificity of the effect for miR-30c-5p, we analysed expression of miR-126. miR-126 expression was reduced in microparticles from serum-starved macrophages and from macrophages treated with high glucose (positive control), 21 but not with oxLDL, suggesting that the effect of oxLDL on miR-30c-5p is specific and does not result from a generalized miRNA deprivation (see Supplementary material online, Figure S3B ). Macrophage apoptosis and release of IL-1b were also significantly increased by oxLDL treatment (Figure 2D-F) . Transfection with a 30c-5p mimetic RNA increased miR-30c-5p levels under basal conditions and after oxLDL treatment. Although an inhibitory effect of oxLDL was still seen in this condition, miR-30c-5p levels in microparticles from oxLDLtreated macrophages were about 3-fold higher in miR-30c-5p mimic RNA transfected cells than in scramble-transfected cells. Importantly, miR-30c-5p overexpression significantly attenuated the effects of oxLDL on apoptosis and IL1-b release by macrophages ( Figure 2D-F) . Collectively, these data suggest that oxLDL induce apoptosis and inflammation in macrophages at least in part by modulating the release of miR-30c-5p.
CD36-oxLDL interaction regulates miR-30c-5p in macrophages
To dissect the mechanisms involved in the downregulation of miR-30c-5p by oxLDL, we tested whether miR-30c-5p in macrophages is regulated at the expression level. Treatment with oxLDL reduced miR-30c-5p expression between 6 and 24 h, while palmitic acid reduced miR-30c-5p after 24 h of exposure. No effect was seen in macrophages treated with high glucose or TNF-a. ( Figure 3A) . CD36 is the major scavenger receptor involved in oxLDL uptake by macrophages, and we found that CD36 knockdown prevented the downregulation of miR-30c-5p induced by oxLDL ( Figure 3B and C) . To check the cell-type specificity of the effect of oxLDL on miR-30c-5p, we performed experiments in endothelial cells. Endothelial cells expressed lower levels of miR-30c-5p, which were unaffected by oxLDL (see Supplementary material online, Figure S4 ).
The CD36-oxLDL pathway affects miR30c processing in macrophages
The miR-30c-5p belongs to miR-30 gene, which is made up of five members, termed miR-30a-e, whose sequence homology is extremely high with 100% conservation in the seed sequence. Human miR-30 is transcribed as a single precursor of 63 nucleotides (pri-miR-30c-1), which is exported from nucleus to cytoplasm through Exportin-5. pri-miR-30c-1 is then cleaved by Dicer and Argonaute pathway to produce mature miRNAs (miR-30c-5p and miR-30c-3p). To investigate the mechanisms whereby oxLDL reduce miR-30c-5p expression in macrophages, we measured the primary transcript pri-miR-30c-1, which reflects the transcriptional activity of the gene: expression of pri-miR-30c-1 was not affected by oxLDL treatment at the time points miR-30c-5p expression changes ( Figure 4A) . Since pri-miR-30c-1 is exported to the cytoplasm and cleaved by Dicer to give mature miRNAs, we analysed Dicer expression in macrophages under ox-LDL treatment. Dicer expression was markedly decreased by ox-LDL, an effect that was not seen in cells with CD36 knockdown. A reduction of Dicer expression was also found when we treated macrophages with H 2 O 2 and this effect was prevented by the SOD mimetic Tempol (30 mM) ( Figure 4B and C) . These data suggest that the effects of oxLDL uptaken by CD36 on Dicer may be mediated by oxidative stress. To assess whether Dicer downregulation is responsible for the reduction in miR-30c-5p content, we overexpressed Dicer in macrophages ( Figure 4C) . The effects of oxLDL on the reduction of miR-30c-5p expression were significantly attenuated in cells overexpressing Dicer ( Figure 4D ).
miR-30c-5p targets
To gain insight into the functional role of miR-30c-5p in atherosclerosis progression, we analysed its potential targets using MirWalk 2.0, a suite of 12 existing miRNA-target prediction programs. We selected gene targets for miR-30c-5p for atherosclerosis network through the gene ontology functional analysis and the gene ontology biological process. We found that a large proportion of gene targets for miR-30c-5p are implicated in apoptosis, lipid metabolism, inflammation, and monocyte/ macrophage differentiation. Using Cytoscape, we created a biological network showing the match of predictive targets for miR-30c-5p in the four pathways and atherosclerosis disease (see Supplementary material online, Figure S5 ). We next sought to validate the targets of the miR-30c-5p with proatherosclerotic properties in macrophages from THP-1 cells, selecting those with sites matching the seed region of miRNA higher than 6mer, 22 and excluding those that are not expressed or expressed at low levels in macrophages according to BioGPS. With these criteria, we found six putative gene targets: ADAM9, CASP3, SERPINE1, TP53, SOCS1, and SOCS3.
We set up a series of in vitro experiments wherein all candidate targets were assessed in macrophages treated with oxLDL and other stimuli compared with control condition. We found that Caspase-3 was the target gene most strongly affected by oxLDL and, less prominently, by palmitic acid ( Figure 5A and see Supplementary material online, Figure S6 ). In addition, when the uptake of oxLDL was blocked by silencing CD36, the effect of oxLDL on caspase-3 upregulation was completely abolished ( Figure 5B) . A reporter assay (CASP3 miRNA 3 0 UTR wild-type target sequence) confirmed that CASP3 is a target of miR-30c-5p, while the deletion of miR-30c-5p target sequence on the 3 0 UTR reporter (CASP3 miRNA 3 0 UTR mutant sequence) abolished this effect, suggesting that CASP3 is a specific target of miR-30c-5p ( Figure 5C ). To further validate the hypothesis that Caspase-3 is regulated by miR-30c-5p during oxLDL treatment, we transfected macrophages with synthetic miR-30c-5p (miR-30c-5p mimic): the overexpression of miR-30c-5p decreased the ability of oxLDL to induce Caspase-3 expression ( Figure 5D ).
MPs transport miR-30c-5p into macrophages
As we hypothesize that miR-30c-5p loaded into microparticles exerts a pro-atherogenic autocrine/paracrine function, we studied whether macrophage-derived microparticles can transfer miR-30c-5p to neighbouring cells, thus regulating the expression of its target genes in recipient cells. First, we confirmed the ability of macrophages to internalize Figure 6A) . Then, we isolated MPs from macrophages in three different conditions: (i) transfection with miR-30c-5p mimic (high miR-30c-5p content), (ii) treated with oxLDL (low miR-30c-5p content); (iii) starvation (unaffected miR-30c-5p content). Macrophages were exposed to MPs generated under these conditions and miR-30c-5p and Caspase-3 expression levels were measured. miR-30c-5p in target macrophages was markedly increased after the incubation with miR-30c-5p overexpressing MPs (mimic), and was significantly lower in macrophages treated with miR-30c-5p depleted MPs (oxLDL) ( Figure 6B ). As expected, Caspase-3 protein expression showed an opposite regulation ( Figure 6C ). These findings support the role of microparticles as a vehicle for miR-30c-5p and their paracrine/autocrine activity in macrophages.
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miR-30c-5p downregulation worsens vascular repair in vivo
To gather in vivo insight on the effects of miR-30c-5p on vascular disease, we employed the electrical carotid injury model. We first verified that macrophages are involved in this model: carotid endothelial injury was followed, within 3 d, by a 6.6-fold increase in the number of infiltrating CD115 -Gr-1 -F4/80 þ macrophages (P = 0.002), whereas no significant increase in CD115 þ Gr-1 -F4/80 -monocytes was observed ( Figure 7A) .
Therefore, we hypothesized that modulating miR-30c-5p in this model would provide valuable data on its role in endothelial response to injury, which is one of the earliest steps in atherogenesis. To this end, we knocked-down miR-30c-5p by treating mice with a specific antagomir by subcutaneous injection starting one day before inducing carotid endothelial damage ( Figure 7B) . Expression of miR-30c-5p was abated by 86% in the liver, >90% in plasma, 72% in the injured carotid, and 65% in the contralateral uninjured carotid, indicating a highly efficient and widespread knock-down. Caspase-3 protein expression was induced in injured as compared with the control carotid, which was significantly worsened by in vivo miR-30c-5p knockdown ( Figure 7C ). Endothelial repair was significantly worsened by miR-30c-5p knock-down, as evidenced by the 60% larger residual Evans blue staining, indicating persistent endothelial damage ( Figure 7D ).
Discussion
This study shows that reduction of circulating miR-30c-5p is associated with intima-media thickening, early atherosclerosis, and precedes plaque development by up to 11 years. As plaque development in this population was mainly associated with raised cholesterol levels, we focused on lipotoxicity to dissect in vitro the meaning of these findings. We found that downregulation of miR-30c-5p occurred after treating macrophages with oxLDL via a CD36-dependent pathway involving suppression of cellular Dicer levels. In turn, miR-30c-5p reduction mediated the detrimental effects of oxLDL on IL-1b release and macrophage apoptosis, both of which were significantly prevented by a miR-30c-5p mimic. As a consequence of oxLDL uptake via CD36 and miR-30c-5p suppression, Caspase-3, one of the predicted targets of miR-30c-5p, was induced at a transcriptional and protein level, which mediated macrophage apoptosis. Most extracellular miR-30c-5p appeared to be loaded into microparticles, and microparticles were found to consistently transfer miR-30c-5p levels and Caspase-3 regulation to neighbouring macrophages, illustrating a typical autocrine/paracrine activity of secreted miRNAs. As inflammation and macrophage apoptosis are well-known contributors to the atherosclerotic process, we hypothesized that these pathways may be relevant to atherosclerosis development. We tested 
this hypothesis in the mouse carotid endothelial injury model, wherein macrophages are involved. In fact, although endothelial injury is mainly expected to result in endothelial dysfunction, it also constitutes the first step in atherogenesis that precedes IMT. We performed an in vivo gene knockdown by systemic administration of a specific miR-30c-5p antagomir, which resulted in a significant miR knockdown in the liver, plasma, as well as in carotid arteries. A pro-apoptotic pathway appears to be activated in the injured artery, as Caspase-3 levels were higher than in the contralateral carotid. As expected by target prediction and based on our in vitro data, Caspase-3 protein induction was worsened by miR-30c-5p knockdown. We found that healing of the endothelial damage was significantly impaired by miR-30c-5p reduction, thus lending support to the causal pathogenic role of the miR-30c-5p downregulation associated with IMT and plaque development in humans. Therefore, our data suggest that preserving miR-30c-5p levels may result in vascular protection against the early stages of atherosclerosis.
We recognize that the consequence of macrophage apoptosis may differ according to disease stage, being possibly protective in the early stages while more detrimental in well-developed plaques. 4, 5 We herein found that in vivo miR-30c-5p silencing resulted in an impaired endothelial recovery after damage with simultaneous induction of apoptosis.
However, in addition to relieving the brakes to Caspase-3 expression, miR-30c-5p reduction also stimulated inflammation, as evidenced by the release of IL-1b. Therefore, a more complex pro-inflammatory state, not limited to apoptosis, is induced within macrophages by miR-30c-5p suppression, as it results from oxLDL treatment. Notably, miR-30c-5p has been previously implicated in inhibiting lipoprotein synthesis in the liver, and was found to improve hypercholesterolemia and atherosclerosis in mice. 23, 24 The short term miR-30c-5p antagomir treatment allows us to rule out that the effects on endothelial healing are mediated by changes in plasma lipids. It should be noted that palmitic acid, a saturated fatty acid found in many dietary components and possibly related to atherosclerosis progression, 25 exerted similar effects on miR-30c-5p as oxLDL. This adds to the lipotoxic pathways potentially leading to atherosclerosis. In this study, we used macrophages derived from THP-1 cells, a human leukemic monocytic cell line often employed to model pathophysiological responses of macrophages in the cardiovascular system. 19 This model overcomes the extreme variability observed in primary macrophages obtained from human blood monocytes. Among limitations of this study, we acknowledge that the role of miR30c-5p was evaluated in macrophages and not in endothelial cells, and an eventual interplay between macrophages and endothelial function was not investigated. 7 In addition, the local expression of miR-30c-5p in human carotid plaques may be of interest and will be evaluated in future studies. Our results on miR-30c-5p are in line with previous studies but highlights a completely new pathway. 26, 27 In fact, in addition to the role on liver lipid metabolism, 23, 24 previous studies mainly focused on smooth muscle cells as a target of miR-30c-5p and on medial hyperplasia or calcification as the result of its downregulation. 26, 27 Importantly, we identified miR-30c-5p as a potential modulator of the atherosclerotic pathway by an unbiased screening of circulating miRNAs associated with atherosclerosis in humans and we provide data in support of an autocrine/paracrine activity of miR-30c-5p loaded into microparticles. Intriguingly, we speculate that the anti-atherosclerotic and anti-inflammatory effects of miR-30c-5p may be conveyed simultaneously at a systemic level by circulating microparticles. While this hypothesis needs to be verified, we argue that the therapeutic role of miR-30c-5p goes well beyond its role on lipoprotein synthesis, involving anti-inflammatory pathways critical for plaque development, thereby making this epigenetic regulator a topranked target for innovative therapies.
Supplementary material
Supplementary material is available at Cardiovascular Research online. The left part shows levels of miR-30c-5p (normalized to snoRNA202 as an endogenous control) in the liver, plasma, injured and uninjured carotid in mice treated with miR-30c-5p antagomir or scramble control. The right part shows CASP3 protein expression in the liver, injured, and uninjured control carotids in mice treated with miR-30c-5p antagomir or scramble control (*P < 0.05 for each t-test comparison of mice treated with antagomir vs. scrambled; n = 6). (D) Endothelial healing, evidenced by Evans blue staining carotid in mice treated with miR-30c-5p antagomir or scrambled control (*P < 0.05 for t-test vs. scrambled; n = 6). Representative gross imaging of carotid arteries dissected under a stereomicroscope is shown. Scatter plots are presented along with median and interquartile range.
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